{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:07:57Z","timestamp":1788865677969,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Saudi Pharm. J."],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Non-responsive cycles during ovulation induction with letrozole (LZ) often necessitate the use of human menopausal gonadotropin (HMG), which may be associated with undesirable adverse effects. Therefore, strategies to improve the therapeutic outcomes of LZ are needed. This trial aimed to evaluate the impact of combining alpha-lipoic acid (ALA) with LZ on ovulation induction in women with polycystic ovary syndrome (PCOS). This randomized controlled trial included 151 infertile women with PCOS who were randomly allocated to either the LZ group (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200976) or the ALA group (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200975). The LZ group received LZ (2.5\u20137.5 mg) with lifestyle modification for up to three treatment cycles or until pregnancy occurred. The ALA group received the same regimen in addition to ALA (1800 mg\/day), which was discontinued on the day of human chorionic gonadotropin (HCG) injection in ovulatory patients. Ovulation and pregnancy rates were assessed, along with hormonal parameters. Ovulation per cycle was significantly higher in the ALA group [153\/166 (92.2%)] compared with the LZ group [146\/203 (71.9%)] (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.035). Moreover, pregnancy per cycle was significantly higher in the ALA group than in the LZ group (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.033). Although serum estradiol, mid-luteal progesterone, and endometrial thickness showed numerically higher values in the ALA group, the differences between the groups were not statistically significant after Bonferroni adjustment. The addition of ALA to LZ improved ovulation and pregnancy outcomes and was associated with favorable metabolic and hormonal effects in women with PCOS.\n                  <\/jats:p>","DOI":"10.1007\/s44446-026-00084-0","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:02:50Z","timestamp":1787126570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of alpha-lipoic acid supplementation on polycystic ovary syndrome clinical outcome in infertile females treated with letrozole: a randomized controlled trial"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7458-9528","authenticated-orcid":false,"given":"Moaz Ahmed","family":"Sallam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6987-596X","authenticated-orcid":false,"given":"Haitham","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5295-6926","authenticated-orcid":false,"given":"Sara Mahmoud","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5193-9523","authenticated-orcid":false,"given":"Marwa Adel","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"issue":"3","key":"84_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00404-020-05951-2","volume":"303","author":"S Abraham Gnanadass","year":"2021","unstructured":"Abraham Gnanadass S, Divakar Prabhu Y, Valsala Gopalakrishnan A (2021) Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet 303(3):631\u2013643. https:\/\/doi.org\/10.1007\/s00404-020-05951-2","journal-title":"Arch Gynecol Obstet"},{"key":"84_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12986-018-0274-y","volume":"15","author":"M Akbari","year":"2018","unstructured":"Akbari M, Ostadmohammadi V, Tabrizi R, Mobini M, Lankarani KB, Moosazadeh M, Heydari ST, Chamani M, Kolahdooz F, Asemi Z (2018) The effects of alpha-lipoic acid supplementation on inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab 15:1\u201310","journal-title":"Nutr Metab"},{"issue":"8","key":"84_CR3","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/humrep\/dex227","volume":"32","author":"SA Amer","year":"2017","unstructured":"Amer SA, Smith J, Mahran A, Fox P, Fakis A (2017) Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Hum Reprod 32(8):1631\u20131638. https:\/\/doi.org\/10.1093\/humrep\/dex227","journal-title":"Hum Reprod"},{"key":"84_CR4","doi-asserted-by":"crossref","unstructured":"Ansar H, Mazloom Z, Kazemi F, Hejazi N (2011) Effect of alpha-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients. Saudi Med J 32(6):584-588. https:\/\/pubmed.ncbi.nlm.nih.gov\/21666939\/","DOI":"10.15537\/1658-3175.5312"},{"issue":"2","key":"84_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1210\/endo.135.2.8033800","volume":"135","author":"RF Aten","year":"1994","unstructured":"Aten RF, Kolodecik TR, Behrman HR (1994) Ovarian vitamin E accumulation: evidence for a role of lipoproteins. Endocrinology 135(2):533\u2013539. https:\/\/doi.org\/10.1210\/endo.135.2.8033800","journal-title":"Endocrinology"},{"key":"84_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1294339","volume":"14","author":"L-J Chen","year":"2024","unstructured":"Chen L-J, Liu Y, Zhang L, Li J-Y, Xiong W-Q, Li T, Ding H, Li B-J (2024) Sequential 2.5 mg letrozole\/FSH therapy is more effective for promoting pregnancy in infertile women with PCOS: a pragmatic randomized controlled trial. Front Endocrinol 14:1294339. https:\/\/doi.org\/10.3389\/fendo.2023.1294339","journal-title":"Front Endocrinol"},{"key":"84_CR7","doi-asserted-by":"publisher","DOI":"10.2147\/ijwh.s345853","author":"X Cheng","year":"2022","unstructured":"Cheng X, He B (2022) Clinical and biochemical potential of antioxidants in treating polycystic ovary syndrome. Int J Womens Health. https:\/\/doi.org\/10.2147\/ijwh.s345853","journal-title":"Int J Womens Health"},{"issue":"2","key":"84_CR8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.rbmo.2022.08.002","volume":"46","author":"X Dai","year":"2023","unstructured":"Dai X, Li J, Fu T, Long X, Li X, Weng R, Liu Y, Zhang L (2023) Ovulation induction using sequential letrozole\/gonadotrophin in infertile women with PCOS: a randomized controlled trial. Reprod Biomed Online 46(2):352\u2013361. https:\/\/doi.org\/10.1016\/j.rbmo.2022.08.002","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"84_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.21608\/vmjg.2024.255839.1029","volume":"70","author":"SH Elmosalamy","year":"2024","unstructured":"Elmosalamy SH, Ahmed ZSO, Elleithy EM, Rashad MM, Ali GE, Hassan NH (2024) Novel therapeutic insights of Alpha lipoic acid: antioxidant, and steroidogenesis regulatory role in letrozole induced PCOS rat model. Vet Med J (Giza) 70(1):26\u201345. https:\/\/doi.org\/10.21608\/vmjg.2024.255839.1029","journal-title":"Vet Med J (Giza)"},{"key":"84_CR10","doi-asserted-by":"publisher","unstructured":"ESHRE TR, Group A-SPCW (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19-25. https:\/\/doi.org\/10.1093\/humrep\/deh098","DOI":"10.1093\/humrep\/deh098"},{"issue":"3","key":"84_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/15209150050194279","volume":"2","author":"JL Evans","year":"2000","unstructured":"Evans JL, Goldfine ID (2000) \u03b1-Lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technol Ther 2(3):401\u2013413. https:\/\/doi.org\/10.1089\/15209150050194279","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"84_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4158\/ep.8.1.29","volume":"8","author":"JL Evans","year":"2002","unstructured":"Evans JL, Heymann CJ, Goldfine ID, Gavin LA (2002) Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of \u03b1-lipoic acid. Endocr Pract 8(1):29\u201335. https:\/\/doi.org\/10.4158\/ep.8.1.29","journal-title":"Endocr Pract"},{"issue":"10","key":"84_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9101011","volume":"9","author":"F Fogacci","year":"2020","unstructured":"Fogacci F, Rizzo M, Krogager C, Kennedy C, Georges CM, Kne\u017eevi\u0107 T, Liberopoulos E, Vall\u00e9e A, P\u00e9rez-Mart\u00ednez P, Wenstedt EF (2020) Safety evaluation of \u03b1-lipoic acid supplementation: a systematic review and meta-analysis of randomized placebo-controlled clinical studies. Antioxidants 9(10):1011. https:\/\/doi.org\/10.3390\/antiox9101011","journal-title":"Antioxidants"},{"key":"84_CR14","doi-asserted-by":"publisher","unstructured":"Franik S, Le Q-K, Kremer JA, Kiesel L, Farquhar C (2022) Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome. Cochrane Database Syst Rev (9). https:\/\/doi.org\/10.1002\/14651858.cd010287.pub4","DOI":"10.1002\/14651858.cd010287.pub4"},{"issue":"1","key":"84_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2901393","volume":"2020","author":"F Fruzzetti","year":"2020","unstructured":"Fruzzetti F, Benelli E, Fidecicchi T, Tonacchera M (2020) Clinical and metabolic effects of Alpha\u2010lipoic acid associated with two different doses of Myo\u2010inositol in women with polycystic ovary syndrome. Int J Endocrinol 2020(1):2901393. https:\/\/doi.org\/10.1155\/2020\/2901393","journal-title":"Int J Endocrinol"},{"issue":"12","key":"84_CR16","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3109\/09513590.2012.685205","volume":"28","author":"AD Genazzani","year":"2012","unstructured":"Genazzani AD, Prati A, Santagni S, Ricchieri F, Chierchia E, Rattighieri E, Campedelli A, Simoncini T, Artini PG (2012) Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients. Gynecol Endocrinol 28(12):969\u2013973. https:\/\/doi.org\/10.3109\/09513590.2012.685205","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"84_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s40618-017-0782-z","volume":"41","author":"AD Genazzani","year":"2018","unstructured":"Genazzani AD, Shefer K, Della Casa D, Prati A, Napolitano A, Manzo A, Despini G, Simoncini T (2018) Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients. J Endocrinol Investig 41(5):583\u2013590. https:\/\/doi.org\/10.1007\/s40618-017-0782-z","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"84_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2024.2341701","volume":"40","author":"AD Genazzani","year":"2024","unstructured":"Genazzani AD, Battipaglia C, Rusce L, Prampolini G, Aio C, Ricciardiello F, Foschi M, Sponzilli A, Semprini E, Petrillo T (2024) Alpha lipoic acid administration improved both peripheral sensitivity to insulin and liver clearance of insulin reducing potential risk of diabetes and nonalcoholic fatty liver disease in overweight\/obese PCOS patients. Gynecol Endocrinol 40(1):2341701. https:\/\/doi.org\/10.1080\/09513590.2024.2341701","journal-title":"Gynecol Endocrinol"},{"key":"84_CR19","unstructured":"Gharib W (2019) The effect of adding L-Carnitine to induction of ovulation with letrozole among PCOS patients. Austin J Obstet Gynecol 6(3):1141. https:\/\/austinpublishinggroup.com\/obstetrics-gynecology\/fulltext\/ajog-v6-id1141.php"},{"issue":"44","key":"84_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000013038","volume":"97","author":"H-j Guang","year":"2018","unstructured":"Guang H-j, Li F, Shi J (2018) Letrozole for patients with polycystic ovary syndrome: a retrospective study. Medicine 97(44):e13038. https:\/\/doi.org\/10.1097\/md.0000000000013038","journal-title":"Medicine"},{"issue":"14","key":"84_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/nu15143209","volume":"15","author":"A Guarano","year":"2023","unstructured":"Guarano A, Capozzi A, Cristodoro M, Di Simone N, Lello S (2023) Alpha lipoic acid efficacy in PCOS treatment: what is the truth? Nutrients 15(14):3209. https:\/\/doi.org\/10.3390\/nu15143209","journal-title":"Nutrients"},{"key":"84_CR22","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s11745-016-4185-2","volume":"51","author":"J Guo","year":"2016","unstructured":"Guo J, Gao S, Liu Z, Zhao R, Yang X (2016) Alpha-lipoic acid alleviates acute inflammation and promotes lipid mobilization during the inflammatory response in white adipose tissue of mice. Lipids 51:1145\u20131152","journal-title":"Lipids"},{"issue":"2","key":"84_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5115\/acb.21.242","volume":"55","author":"R Jannatifar","year":"2022","unstructured":"Jannatifar R, Piroozmanesh H, Sahraei SS, Asa E (2022) Combination of alpha lipoic acid and metformin supplement improve assisted reproductive technologies outcomes in polycystic ovary syndrome patients. Anatomy Cell Biol 55(2):239\u2013246. https:\/\/doi.org\/10.5115\/acb.21.242","journal-title":"Anatomy Cell Biol"},{"issue":"3","key":"84_CR24","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4103\/0974-1208.106338","volume":"5","author":"S Kar","year":"2012","unstructured":"Kar S (2012) Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial. J Hum Reprod Sci 5(3):262\u2013265. https:\/\/doi.org\/10.4103\/0974-1208.106338","journal-title":"J Hum Reprod Sci"},{"issue":"1","key":"84_CR25","doi-asserted-by":"publisher","first-page":"85. e81","DOI":"10.1016\/j.amjmed.2010.08.005","volume":"124","author":"EH Koh","year":"2011","unstructured":"Koh EH, Lee WJ, Lee SA, Kim EH, Cho EH, Jeong E, Kim DW, Kim M-S, Park J-Y, Park K-G (2011) Effects of alpha-lipoic acid on body weight in obese subjects. Am J Med 124(1):85. e81-85. e88. https:\/\/doi.org\/10.1016\/j.amjmed.2010.08.005","journal-title":"Am J Med"},{"issue":"12","key":"84_CR26","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK (2013) Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 98(12):4565\u20134592. https:\/\/doi.org\/10.1210\/jc.2013-2350","journal-title":"J Clin Endocrinol Metab"},{"key":"84_CR27","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s10753-014-9957-3","volume":"38","author":"G Li","year":"2015","unstructured":"Li G, Fu J, Zhao Y, Ji K, Luan T, Zang B (2015) Alpha-lipoic acid exerts anti-inflammatory effects on lipopolysaccharide-stimulated rat mesangial cells via inhibition of nuclear factor kappa B (NF-\u03baB) signaling pathway. Inflammation 38:510\u2013519","journal-title":"Inflammation"},{"issue":"7421","key":"84_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7421.951","volume":"327","author":"JM Lord","year":"2003","unstructured":"Lord JM, Flight IH, Norman RJ (2003) Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 327(7421):951. https:\/\/doi.org\/10.1136\/bmj.327.7421.951","journal-title":"BMJ"},{"issue":"8","key":"84_CR29","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1021\/jf904403u","volume":"58","author":"X Ma","year":"2010","unstructured":"Ma X, He P, Sun P, Han P (2010) Lipoic acid: an immunomodulator that attenuates glycinin-induced anaphylactic reactions in a rat model. J Agric Food Chem 58(8):5086\u20135092. https:\/\/doi.org\/10.1021\/jf904403u","journal-title":"J Agric Food Chem"},{"key":"84_CR30","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1590\/s0004-27302008000900010","volume":"52","author":"IR Madeira","year":"2008","unstructured":"Madeira IR, Carvalho CNM, Gazolla FM, Matos HJd, Borges MA, Bordallo MAN (2008) Cut-off point for Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) index established from Receiver Operating Characteristic (ROC) curve in the detection of metabolic syndrome in overweight pre-pubertal children. Arquivos Brasileiros De Endocrinologia Metabologia 52:1466\u20131473. https:\/\/doi.org\/10.1590\/s0004-27302008000900010","journal-title":"Arquivos Brasileiros De Endocrinologia Metabologia"},{"issue":"4","key":"84_CR31","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3390\/ijms22041667","volume":"22","author":"A Mancini","year":"2021","unstructured":"Mancini A, Bruno C, Vergani E, d\u2019Abate C, Giacchi E, Silvestrini A (2021) Oxidative stress and low-grade inflammation in polycystic ovary syndrome: controversies and new insights. Int J Mol Sci 22(4):1667. https:\/\/doi.org\/10.3390\/ijms22041667","journal-title":"Int J Mol Sci"},{"issue":"2","key":"84_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1177\/193229681000400218","volume":"4","author":"U Masharani","year":"2010","unstructured":"Masharani U, Gjerde C, Evans JL, Youngren JF, Goldfine ID (2010) Effects of controlled-release alpha lipoic acid in lean, nondiabetic patients with polycystic ovary syndrome. J Diabetes Sci Technol 4(2):359\u2013364. https:\/\/doi.org\/10.1177\/193229681000400218","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"84_CR33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.fertnstert.2018.11.030","volume":"111","author":"RB Mejia","year":"2019","unstructured":"Mejia RB, Summers KM, Kresowik JD, Van Voorhis BJ (2019) A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome. Fertil Steril 111(3):571-578. e571. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.11.030","journal-title":"Fertil Steril"},{"key":"84_CR34","doi-asserted-by":"publisher","DOI":"10.5653\/cerm.2024.07346","author":"AA Morsy","year":"2025","unstructured":"Morsy AA, Sabri NA, Mourad AM, Mojahed EM, Fahmy SF (2025) New insights into pentoxifylline and \u03b1-lipoic acid: Co-administration with clomiphene citrate for ovulation induction in anovulatory women with polycystic ovary syndrome. Korean J Fertil Steril. https:\/\/doi.org\/10.5653\/cerm.2024.07346","journal-title":"Korean J Fertil Steril"},{"issue":"1","key":"84_CR35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4103\/abr.abr_157_17","volume":"7","author":"F Mostajeran","year":"2018","unstructured":"Mostajeran F, Tehrani HG, Rahbary B (2018) N-acetylcysteine as an adjuvant to letrozole for induction of ovulation in infertile patients with polycystic ovary syndrome. Adv Biomed Res 7(1):100. https:\/\/doi.org\/10.4103\/abr.abr_157_17","journal-title":"Adv Biomed Res"},{"key":"84_CR36","doi-asserted-by":"crossref","unstructured":"Mumusoglu S, Sipahi M, Bozdag G (2020) Polycystic ovarian syndrome and medically assisted reproduction. In: Textbook of Assisted Reproduction (pp. 241\u2013248). Springer. https:\/\/link.springer.com\/chapter\/10.1007\/978-981-15-2377-9_28","DOI":"10.1007\/978-981-15-2377-9_28"},{"issue":"3","key":"84_CR37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/humupd\/dms059","volume":"19","author":"M Murri","year":"2013","unstructured":"Murri M, Luque-Ram\u00edrez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF (2013) Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 19(3):268\u2013288. https:\/\/doi.org\/10.1093\/humupd\/dms059","journal-title":"Hum Reprod Update"},{"issue":"10","key":"84_CR38","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20222369","volume":"11","author":"I Nasrin","year":"2022","unstructured":"Nasrin I, Ishrat S, Amir M, Halder S, Rahman F, Kamruzzaman M (2022) Coenzyme q10 and letrozole versus letrozole alone for ovulation induction in polycystic ovary syndrome. Int J Reprod Contracept Obstet Gynecol 11(10):2. https:\/\/doi.org\/10.18203\/2320-1770.ijrcog20222369","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"issue":"3","key":"84_CR39","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/humupd\/dmaa055","volume":"27","author":"J Pundir","year":"2021","unstructured":"Pundir J, Achilli C, Bhide P, Sabatini L, Legro RS, Rombauts L, Teede H, Coomarasamy A, Zamora J, Thangaratinam S (2021) Risk of foetal harm with letrozole use in fertility treatment: a systematic review and meta-analysis. Hum Reprod Update 27(3):474\u2013485. https:\/\/doi.org\/10.1093\/humupd\/dmaa055","journal-title":"Hum Reprod Update"},{"key":"84_CR40","doi-asserted-by":"publisher","unstructured":"Purwar A, Nagpure S (2022) Insulin resistance in polycystic ovarian syndrome. Cureus 14(10). https:\/\/doi.org\/10.7759\/cureus.30351","DOI":"10.7759\/cureus.30351"},{"issue":"4","key":"84_CR41","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00404-011-1951-5","volume":"284","author":"F Ramezanzadeh","year":"2011","unstructured":"Ramezanzadeh F, Nasiri R, Sarafraz Yazdi M, Baghrei M (2011) A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS. Arch Gynecol Obstet 284(4):1029\u20131034. https:\/\/doi.org\/10.1007\/s00404-011-1951-5","journal-title":"Arch Gynecol Obstet"},{"issue":"12","key":"84_CR42","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1139\/cjpp-2014-0353","volume":"93","author":"L Rochette","year":"2015","unstructured":"Rochette L, Ghibu S, Muresan A, Vergely C (2015) Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes. Can J Physiol Pharmacol 93(12):1021\u20131027. https:\/\/doi.org\/10.1139\/cjpp-2014-0353","journal-title":"Can J Physiol Pharmacol"},{"issue":"7","key":"84_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka E, Suchta K, Grymowicz M, Calik-Ksepka A, Smolarczyk K, Duszewska AM, Smolarczyk R, Meczekalski B (2021) Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci 22(7):3789. https:\/\/doi.org\/10.3390\/ijms22073789","journal-title":"Int J Mol Sci"},{"issue":"3","key":"84_CR44","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00404-024-07607-x","volume":"310","author":"N Salari","year":"2024","unstructured":"Salari N, Nankali A, Ghanbari A, Jafarpour S, Ghasemi H, Dokaneheifard S, Mohammadi M (2024) Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis. Arch Gynecol Obstet 310(3):1303\u20131314. https:\/\/doi.org\/10.1007\/s00404-024-07607-x","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"84_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/10715769409147509","volume":"20","author":"BC Scott","year":"1994","unstructured":"Scott BC, Aruoma OI, Evans PJ, O\u2019neill C, Van Der Vliet A, Cross CE, Tritschler H, Halliwell B (1994) Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation. Free Radic Res 20(2):119\u2013133. https:\/\/doi.org\/10.3109\/10715769409147509","journal-title":"Free Radic Res"},{"key":"84_CR46","doi-asserted-by":"publisher","unstructured":"Sharma P, Chandra R, Sarkar A, Jindal S, Sharma A, Sharma JC, Jaggarwal S (2023) Assessment of fertility outcomes following combined clomiphene and letrozole versus letrozole therapy for the treatment of polycystic ovarian syndrome subfertility. Cureus 15(5). https:\/\/doi.org\/10.7759\/cureus.38886","DOI":"10.7759\/cureus.38886"},{"key":"84_CR47","doi-asserted-by":"publisher","unstructured":"Sharpe A, Morley LC, Tang T, Norman RJ, Balen AH, Gynaecology C, Group F (1996) Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2019(12). https:\/\/doi.org\/10.1002\/14651858.cd013505","DOI":"10.1002\/14651858.cd013505"},{"issue":"10","key":"84_CR48","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.bbagen.2009.07.026","volume":"1790","author":"KP Shay","year":"2009","unstructured":"Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM (2009) Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochimica Et Biophysica Acta (BBA)-Gen Subj 1790(10):1149\u20131160. https:\/\/doi.org\/10.1016\/j.bbagen.2009.07.026","journal-title":"Biochimica Et Biophysica Acta (BBA)-Gen Subj"},{"key":"84_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1059609","volume":"13","author":"L Shi","year":"2022","unstructured":"Shi L, Ye S, Gao M, Chen Y, Jin X, Zhang Z (2022) Effect of different timing of letrozole initiation on pregnancy outcome in polycystic ovary syndrome. Front Endocrinol 13:1059609. https:\/\/doi.org\/10.3389\/fendo.2022.1059609","journal-title":"Front Endocrinol"},{"issue":"2","key":"84_CR50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1262\/jrd.50.215","volume":"50","author":"N Sugino","year":"2004","unstructured":"Sugino N, Karube-Harada A, Taketani T, Sakata A, Nakamura Y (2004) Withdrawal of ovarian steroids stimulates prostaglandin F2\u03b1 production through nuclear factor-\u03baB activation via oxygen radicals in human endometrial stromal cells: potential relevance to menstruation. J Reprod Dev 50(2):215\u2013225. https:\/\/doi.org\/10.1262\/jrd.50.215","journal-title":"J Reprod Dev"},{"issue":"4","key":"84_CR51","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/s1472-6483(10)60926-1","volume":"8","author":"B Urman","year":"2004","unstructured":"Urman B, Tiras B, Yakin K (2004) Assisted reproduction in the treatment of polycystic ovarian syndrome. Reprod Biomed Online 8(4):419\u2013430. https:\/\/doi.org\/10.1016\/s1472-6483(10)60926-1","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"84_CR52","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/humupd\/dmz029","volume":"25","author":"R Wang","year":"2019","unstructured":"Wang R, Li W, Bordewijk EM, Legro RS, Zhang H, Wu X, Gao J, Morin-Papunen L, Homburg R, K\u00f6nig TE (2019) First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis. Hum Reprod Update 25(6):717\u2013732. https:\/\/doi.org\/10.1093\/humupd\/dmz029","journal-title":"Hum Reprod Update"},{"key":"84_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1169232","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang J, Yin T, Liu S (2023) Dysregulation of immune response in PCOS organ system. Front Immunol 14:1169232. https:\/\/doi.org\/10.3389\/fimmu.2023.1169232","journal-title":"Front Immunol"},{"key":"84_CR54","doi-asserted-by":"publisher","unstructured":"Weiss NS, Kostova E, Nahuis M, Mol BWJ, Van der Veen F, van Wely M (2019) Gonadotrophins for ovulation induction in women with polycystic ovary syndrome. Cochrane Database Syst Rev (1). https:\/\/doi.org\/10.1002\/14651858.cd010290.pub3","DOI":"10.1002\/14651858.cd010290.pub3"},{"issue":"1","key":"84_CR55","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3892\/mmr.2017.6604","volume":"16","author":"L Wu","year":"2017","unstructured":"Wu L, Sun Y, Wan J, Luan T, Cheng Q, Tan Y (2017) A proteomic analysis identifies candidate early biomarkers to predict ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients. Mol Med Rep 16(1):272\u2013280. https:\/\/doi.org\/10.3892\/mmr.2017.6604","journal-title":"Mol Med Rep"},{"issue":"12","key":"84_CR56","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/jcph.2318","volume":"63","author":"TT Xia","year":"2023","unstructured":"Xia TT, Zeng KF, Peng QM (2023) Comparison of three ovulation induction therapies for patients with polycystic ovary syndrome and infertility. J Clin Pharmacol 63(12):1371\u20131376. https:\/\/doi.org\/10.1002\/jcph.2318","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"84_CR57","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00011-010-0256-7","volume":"60","author":"Z Ying","year":"2011","unstructured":"Ying Z, Kampfrath T, Sun Q, Parthasarathy S, Rajagopalan S (2011) Evidence that \u03b1-lipoic acid inhibits NF-\u03baB activation independent of its antioxidant function. Inflamm Res 60(3):219\u2013225. https:\/\/doi.org\/10.1007\/s00011-010-0256-7","journal-title":"Inflamm Res"},{"issue":"3","key":"84_CR58","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoae046","volume":"2024","author":"X Zhu","year":"2024","unstructured":"Zhu X, Lang J, Wang Q, Fu Y (2024) Extended versus conventional letrozole regimen in patients with polycystic ovary syndrome undergoing their first ovulation induction cycle: a prospective randomized controlled trial. Hum Reprod Open 2024(3):hoae046. https:\/\/doi.org\/10.1093\/hropen\/hoae046","journal-title":"Hum Reprod Open"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44446-026-00084-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44446-026-00084-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44446-026-00084-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:17:42Z","timestamp":1788862662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44446-026-00084-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["84"],"URL":"https:\/\/doi.org\/10.1007\/s44446-026-00084-0","relation":{},"ISSN":["1319-0164","2213-7475"],"issn-type":[{"value":"1319-0164","type":"print"},{"value":"2213-7475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Faculty of Pharmacy Ethics Committee, Ain Shams University (ACUC-FP-ASU).","order":2,"name":"Ethics","label":"Ethical statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"54"}}